X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

By Andrew Powaleny  |    May 11, 2023
America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health...   Read More

Support for continued progress is critical for pediatric drug development

By Abigail Lore  |    May 8, 2023
Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our...   Read More

New resource underscores the importance of small molecule medicines

By Lindsey Seidlitz  |    May 4, 2023
A small molecule medicine is what most people think of when they imagine a medicine. These medicines typically come in the form of a tablet or capsule and are usually taken by mouth. These medicines...   Read More

Policies need to address the growing threat of antimicrobial resistance

By Jocelyn Ulrich  |    April 28, 2023
Today, the House Energy & Commerce Subcommittee on Oversight and Investigations will be holding a hearing on the growing public health threat of antimicrobial resistance (AMR). AMR occurs when...   Read More

World IP Day 2023: Celebrating women leaders in innovation

By Megan Van Etten  |    April 26, 2023
Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s...   Read More

CMS guidance on IRA price setting process doubles down on bad policy

By Nicole Longo  |    April 14, 2023
As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The...   Read More

A guide to MedPAC’s Part B vote today

By Nicole Longo  |    April 13, 2023
Today, the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues related to the Medicare program, will vote on draft recommendations...   Read More

ICYMI: PhRMA President and CEO Stephen J. Ubl discusses patient affordability

By Emilie Signora  |    April 7, 2023
PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’s event, “Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re...   Read More

New Report: More than 400 medicines in development for leading chronic conditions affecting older Americans

By Lucy Vereshchagina  |    March 28, 2023
Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and...   Read More

Celebrating the success of the COVID-19 vaccines, and looking to the future

By Michael Ybarra  |    March 27, 2023
It’s been over three years since I saw my first COVID-19 patient in the emergency department. The image of that x-ray is burned into my memory: clusters of white spots spread out across both sides of...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates